BillionToOne logo

BillionToOne, Inc


BillionToOne Stock

Founded in 2016, BilliontoOne is a next-generation diagnostics company with a mission to make molecular diagnostics more accurate, efficient, and accessible for all. BillionToOne’s noninvasive prenatal genetic testing, UNITY, is reportedly the only prenatal test that can examine both the pregnant mother & the baby for single-gene disorders from one blood sample.

Management Team

Oguzhan Atay, PhD Co-Founder and CEO
David Tsao, PhD Co-Founder and CTO
Nipun Soni CFO
Gary Palmer, MD Chief Medical Officer, Oncology

Funding Information